发明名称 非常に速い皮膚透過率を有するアリール−及びヘテロアリールプロピオン酸の正荷電水溶性プロドラッグ
摘要 PROBLEM TO BE SOLVED: To avoid side effects of NSAIA by enhancing solubility of NSAIA in gastric juices, and enhancing its permeability through membranes and skin barriers, which may make it applicable for transdermal administration (topical application).SOLUTION: Novel positive charge water soluble prodrugs of aryl- or heteroaryl-propionic acid represented by formula (1) and formula (2) are synthesized. The prodrugs are distributed through human skin 100 to 130 times faster than parent drugs thereof. The prodrugs reach a peak plasma level in only about 40 to 50 minutes when the prodrugs are administrated transdermally. The prodrugs are used pharmaceutically with not only oral administration, but also transdermal administration for a treatment of NSAIA-remediable situation in human or animals and can avoid most of side effects of NSAIA.
申请公布号 JP5940036(B2) 申请公布日期 2016.06.29
申请号 JP20130211332 申请日期 2013.10.08
申请人 テックフィールズ バイオケム カンパニー リミテッド;ユー チョンシー 发明人 ユー チョンシー;シュー リナ
分类号 C07C219/10;A61K9/12;A61K9/70;A61K31/216;A61K31/381;A61K31/40;A61K31/421;A61P1/02;A61P1/08;A61P3/10;A61P7/04;A61P11/06;A61P15/08;A61P17/16;A61P19/02;A61P19/08;A61P21/00;A61P25/00;A61P25/04;A61P25/06;A61P27/02;A61P27/06;A61P27/16;A61P29/00;A61P35/00;C07C213/06;C07D207/20;C07D209/26;C07D263/57;C07D333/24 主分类号 C07C219/10
代理机构 代理人
主权项
地址
您可能感兴趣的专利